91
Growth Score in past quarter
pts
Heat Score 91 in past quarter
28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
344404
Apollon Formularies specializes in medical cannabis pharmaceuticals for cancer and chronic pain treatment.
Stephen D. Barnhill: PresidentPast Role: Health Discovery, Founder, Chairman and CEO
Stephen D. Barnhill: Chairman and CEOPast Role: Health Discovery, Founder, Chairman and CEO
About the Company
Apollon Formularies is a biotechnology company specializing in medical cannabis pharmaceuticals. The company focuses on research and treatment for patients with cancer and chronic pain. Apollon Formularies operates under the approval of the Cannabis Licensing Authority to produce large-scale full-spectrum cannabis oils. The company collaborates
with the Jamaica Cancer Care and Research Institute (JACCRI) to advance its medical research and treatment capabilities.